Siguazodan is a phosphodiesterase inhibitor.[1]

References

  1. ^ Sosroseno, W; Sugiatno, E (2008). "Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: Effect of exogenous nitric oxide". Acta Biomedica. 79 (2): 110–6. PMID 18788505.


Allikas: http://en.wikipedia.org/wiki/Siguazodan
No tags for this post.